Premium
A novel clinical prediction rule for 30‐day mortality following balloon aortic valuloplasty: The CRRAC the AV score
Author(s) -
Elmariah Sammy,
Lubitz Steven A.,
Shah Amil M.,
Miller Marc A.,
Kaplish Dheeraj,
Kothari Sharad,
Moreno Pedro R.,
Kini Annapoorna S.,
Sharma Samin K.
Publication year - 2011
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.22912
Subject(s) - medicine , aortic valvuloplasty , receiver operating characteristic , cardiology , percutaneous , framingham risk score , aortic valve stenosis , proportional hazards model , aortic valve , stenosis , risk of mortality , euroscore , aortic valve replacement , balloon , surgery , cardiac surgery , disease
Abstract Objectives : We seek to identify predictors of 30‐day mortality after balloon aortic valvuloplasty (BAV). Background : To date, there is no validated method of predicting patient outcomes after percutaneous aortic valve interventions. Methods : Data for consecutive patients with severe aortic stenosis who underwent BAV at the Mount Sinai Medical Center from January 2001 to July 2007 were retrospectively reviewed. Cox‐proportional hazards regression was used to identify significant predictors of 30‐day mortality, and the resultant model was compared to the EuroSCORE using Akaike's Information Criterion and area under the receiver‐operating curve (AUC). Results : The analysis included 281 patients (age 83 ± 9 years, 61% women, aortic valve area: 0.64 ± 0.2 cm 2 ) and 36 (12.8%) of whom died within 30 days of BAV. With identified risk factors for 30‐day mortality, critical status, renal dysfunction, right atrial pressure, and cardiac output, we constructed the CRRAC the AV risk score. Thirty‐day survival was 72% in the highest tertile versus 94% in the lower two tertiles of the score. Compared to the additive and logistic EuroSCORE, the risk score demonstrated superior discrimination (AUC = 0.75 vs. 0.60 and 0.63, respectively). Conclusions : We derived a risk score, the CRRAC the AV score that identifies patients at high‐risk of 30‐day mortality after BAV. Validation of the developed risk prediction score, the CRRAC the AV score, is needed in other cohorts of post‐BAV patients and potentially in patients undergoing other catheter‐based valve interventions. © 2010 Wiley‐Liss, Inc.